Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5274 ARTÍCULOS , VIENDO DEL 1306 AL 1320

Neuropsychological Functioning in Primary Dystonia: Updated and Expanded Multidomain Meta-Analysis

Aita SL, Del Bene VA, Marotta DA, Pizer JH, Hawley NA, Niccolai L, Walker HC, Gerstenecker A, Martin RC, Clay OJ, Crowe M, Triebel KL, Hill BD.

Mov Disord. 2022 Jul;37(7):1483-1494. doi: 10.1002/mds.29022. Epub 2022 Apr 6.

Contributions and Limitations of Mitochondria-Targeted and Non-Targeted Antioxidants in the Treatment of Parkinsonism: an Updated Review

Banerjee P, Saha I, Sarkar D, Maiti AK.

Neurotox Res. 2022 Jun;40(3):847-873. doi: 10.1007/s12640-022-00501-x. Epub 2022 Apr 7.

Effects of automatic mechanical peripheral stimulation on gait biomechanics in older adults with Parkinson's disease: a randomized crossover clinical trial

Marques NR, Kuroda MH, Moreno VC, Zámuner AR, Barbieri FA.

Aging Clin Exp Res. 2022 Jun;34(6):1323-1331. doi: 10.1007/s40520-022-02075-2. Epub 2022 Apr 6.

The Emerging Roles of the β-Secretase BACE1 and the Long Non-coding RNA BACE1-AS in Human Diseases: A Focus on Neurodegenerative Diseases and Cancer

Sayad A, Najafi S, Hussen BM, Abdullah ST, Movahedpour A, Taheri M, Hajiesmaeili M.

Front Aging Neurosci. 2022 Mar 21;14:853180. doi: 10.3389/fnagi.2022.853180. eCollection 2022.

Quantifying the inverted U: A meta-analysis of prefrontal dopamine, D1 receptors, and working memory

Weber MA, Conlon MM, Stutt HR, Wendt L, Ten Eyck P, Narayanan NS.

Behav Neurosci. 2022 Jun;136(3):207-218. doi: 10.1037/bne0000512. Epub 2022 Apr 7.

Neuropsychological, neuropsychiatric, and clinical correlates of affective and cognitive theory of mind in Parkinson's disease: A meta-analysis

Maggi G, Cima Muñoz AM, Obeso I, Santangelo G.

Neuropsychology. 2022 Sep;36(6):483-504. doi: 10.1037/neu0000807. Epub 2022 Apr 7.

Correction to: Cerebellar Microstructural Abnormalities in Parkinson's Disease: a Systematic Review of Diffusion Tensor Imaging Studies

Haghshomar M, Shobeiri P, Seyedi SA, Abbasi-Feijani F, Poopak A, Sotoudeh H, Kamali A, Aarabi MH.

Cerebellum. 2022 Aug;21(4):572. doi: 10.1007/s12311-022-01402-7.

Lymphatic Vessel Regression and Its Therapeutic Applications: Learning From Principles of Blood Vessel Regression

Masood F, Bhattaram R, Rosenblatt MI, Kazlauskas A, Chang JH, Azar DT.

Front Physiol. 2022 Mar 22;13:846936. doi: 10.3389/fphys.2022.846936. eCollection 2022.

Impact of occupational pesticide exposure assessment method on risk estimates for prostate cancer, non-Hodgkin's lymphoma and Parkinson's disease: results of three meta-analyses

Ohlander J, Fuhrimann S, Basinas I, Cherrie JW, Galea KS, Povey AC, van Tongeren M, Harding AH, Jones K, Vermeulen R, Huss A, Kromhout H.

Occup Environ Med. 2022 Aug;79(8):566-574. doi: 10.1136/oemed-2021-108046. Epub 2022 Apr 7.

The human microbiome in disease and pathology

Manos J.

APMIS. 2022 Dec;130(12):690-705. doi: 10.1111/apm.13225. Epub 2022 May 6.

Mechanisms regulating the sorting of soluble lysosomal proteins

Meraş İ, Maes J, Lefrancois S.

Biosci Rep. 2022 May 27;42(5):BSR20211856. doi: 10.1042/BSR20211856.

Reducing neuroinflammation via therapeutic compounds and lifestyle to prevent or delay progression of Parkinson's disease

Kip E, Parr-Brownlie LC.

Ageing Res Rev. 2022 Jun;78:101618. doi: 10.1016/j.arr.2022.101618. Epub 2022 Apr 5.

Increased creativity associated with dopamine agonist therapy: A case report and short review of the literature

Thakolwiboon S, Karukote A, Julayanont P, Wilms H.

Clin Neurol Neurosurg. 2022 May;216:107237. doi: 10.1016/j.clineuro.2022.107237. Epub 2022 Apr 1.

Genetic heterogeneity on sleep disorders in Parkinson's disease: a systematic review and meta-analysis

Huang J, Cheng Y, Li C, Shang H.

Transl Neurodegener. 2022 Apr 8;11(1):21. doi: 10.1186/s40035-022-00294-1.

Design of the PERSPECTIVE study: PERsonalized SPEeCh Therapy for actIVE conversation in Parkinson's disease (randomized controlled trial)

Maas JJL, De Vries NM, Bloem BR, Kalf JG.

Trials. 2022 Apr 8;23(1):274. doi: 10.1186/s13063-022-06160-9.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias